Kintor Pharmaceutical Ltd (HK:9939) has released an update.
Kintor Pharmaceutical Ltd is set to hold its annual general meeting on June 20, 2024, in Suzhou, where shareholders will vote on key resolutions including the adoption of financial statements, director re-elections, and auditor appointments. The agenda also includes granting the board authority to issue and repurchase shares, with specific mandates outlined for both actions. Shareholders are encouraged to appoint a proxy to vote on their behalf if they cannot attend in person.
For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.
